Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States,July 2021 |
| |
| Authors: | Hannah G. Rosenblum,Stephen C. Hadler,Danielle Moulia,Tom T. Shimabukuro,John R. Su,Naomi K. Tepper,Kevin C. Ess,Emily Jane Woo,Adamma Mba-Jonas,Meghna Alimchandani,Narayan Nair,Nicola P. Klein,Kayla E. Hanson,Lauri E. Markowitz,Melinda Wharton,Veronica V. McNally,José R. Romero,H. Keipp Talbot,Grace M. Lee,Matthew F. Daley,Sarah A. Mbaeyi,Sara E. Oliver |
| |
| Abstract: | |
| |
| Keywords: | |
|
|
